Despite a robust balance sheet and good liquidity, Pliant Th...

Moomoo AI Nov 20, 2023 23:05

Despite a robust balance sheet and good liquidity, Pliant Therapeutics faced a 64% revenue shrink to US$3.5m last year, questioning its future profitability. After burning through US$124m cash and a US$155m loss, it might need to raise capital soon.

Is Pliant Therapeutics (NASDAQ:PLRX) Using Debt Sensibly?

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

5842 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4668Followers

0Following

10KVisitors